Skip to main content
. Author manuscript; available in PMC: 2017 Oct 26.
Published in final edited form as: Leukemia. 2017 Apr 25;31(12):2791–2798. doi: 10.1038/leu.2017.120

Figure 5.

Figure 5

Nuclear imaging in representative patient

Representative scans of patient I.6.6

A. Baseline 18F-FDG PET scan showing subcutaneous plasmacytomas in legs

B. Baseline pre-treatment 123I SPECT/CT shows no iodine uptake

C. Day +7 post MV-NIS therapy shows 123I uptake in representative subcutanous plasmacytomas

D. Disease progression by day 38 as shown by 18F-FDG PET.